Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

4.8
(68)
Write Review
More
$ 21.99
Add to Cart
In stock
Description

Novus Therapeutics (@Novus_Thera) / X

Blog: Acquisition of Anelixis Therapeutics Fuels Hopes of AT-1501 Push to Phase 2 Clinical Trials

Rite Aid's New CEO, CommonSpirit Health Appoints First Chief Information and Digital Officer, Geisinger's Chief Nursing Exec, Other Health IT Appointments - DistilINFO LifeSciences

SEC Filing Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals - Recent News & Activity

The Daily Biotech Pulse: Marinus Epilepsy Study Meets Goal, Novavax Reaches Vaccine Manufacturing Deal, Outset Medical's IPO

Novus Finalizes Acquisition of Anelixis to Further Develop AT-1501

Eledon Pharmaceuticals Inc - 10K - Annual Report - March 30, 2023

Coeptis Therapeutics closes SPAC deal with Bull Horn

Amanda Sellers's Instagram, Twitter & Facebook on IDCrawl